Skip to main content

Table 4 Multivariate linear regression analysis of the association between dietary fatty acids and High-frequency PTA.

From: Association between nineteen dietary fatty acids and hearing thresholds: findings from a nationwide survey

Fatty acids

Continuous

Q1

Q2

Q3

Q4

P for trend

(energy (%))

β (95% CI)

 

β (95% CI)

β (95% CI)

β (95% CI)

Total SFAs

0.63 (0.06, 1.20)*

0 (ref)

0.56 (0.34, 1.02)*

0.92 (0.15, 1.67)*

1.45 (0.11, 3.09)*

< 0.001

SFA 4:0

1.71 (0.09, 3.43)*

0 (ref)

0.52 (0.14, 1.16)*

1.15 (-0.02, 3.86)

3.49 (1.06, 5.41)*

< 0.001

SFA 6:0

1.06 (-0.28, 3.24)

0 (ref)

-0.01 (-0.33, 0.80)

0.26 (-0.03, 0.73)

1.32 (-0.21, 1.63)

0.016

SFA 8:0

0.17 (-0.08, 0.45)

0 (ref)

-0.01 (-0.72, 0.58)

0.42 (0.04, 0.93)

0.54 (-0.08, 1.10)

0.066

SFA 10:0

0.01 (-1.06, 0.84)

0 (ref)

-0.28 (-0.37, 0.60)

-0.25 (-2.55, 2.02)

0.41 (-3.44, 4.59)

0.103

SFA 12:0

-0.61 (-1.35, 0.38)

0 (ref)

-0.01 (-1.58, 3.21)

-0.24 (-1.28, 1.05)

-0.58 (-4.10, 5.11)

0.661

SFA 14:0

1.01 (-4.11, 5.36)

0 (ref)

0.16 (-1.31, 3.01)

0.11 (-1.47, 2.48)

2.01 (-5.61,9.23)

0.276

SFA 16:0

-0.81 (-2.88, 4.10)

0 (ref)

-0.17 (-0.90, 0.72)

-1.74 (-2.15, 0.81)

-1.36 (-2.22, 0.81)

0.470

SFA 18:0

-0.30 (-0.07, 1.00)

0 (ref)

-0.01 (-1.15, 1.06)

-0.21 (-0.76, 0.30)

-0.16 (-2.10, 1.48)

0.605

Total MUFAs

-0.03 (-0.71, 0.63)

0 (ref)

-0.10 (-2.17, 3.13)

-0.15 (-2.69, 2.00)

-0.31 (-3.18, 3.89)

0.093

MUFA 18:0

-1.11 (-4.61, 7.17)

0 (ref)

0.15 (-0.12, 0.48)

0.30 (-0.71, 1.92)

-1.03 (-4.12, 2.22)

0.676

MUFA 18:1

0.10 (-2.23, 3.01)*

0 (ref)

-0.50 (-4.15, 3.57)

1.31 (-0.21, 1.89)

0.41 (-1.55, 1.84)

0.558

MUFA 20:1

-3.31 (-7.92, 1.06)

0 (ref)

-1.01 (-4.14, 0.88)

-2.55 (-6.72, 1.40)

-3.11 (-9.21, 4.87)

0.035

MUFA 22:1

-1.15 (-5.91, 4.81)

0 (ref)

0.21 (-2.41, 2.88)

-1.11 (-3.04, 1.06)

-1.16 (-5.30, 2.77)

0.138

Total PUFAs

1.32 (0.27, 2.73)*

0 (ref)

0.16 (0.02, 0.36)*

0.49 (0.16, 1.15)*

2.11 (0.15, 4.21)*

< 0.001

PUFA 18:2

1.02 (0.04, 2.06)*

0 (ref)

1.42 (0.08,2.34)*

1.26 (-0.19, 3.02)

4.62 (-1.21, 9.33)

0.055

PUFA 18:3

2.37 (-1.28, 4.48)

0 (ref)

2.03 (-1.35, 4.59)

1.90 (-1.23, 4.31)

1.05 (-0.66, 2.21)

0.417

PUFA 18:4

0.53 (-1.07, 3.32)

0 (ref)

-0.08 (-1.54, 1.89)

1.50 (-3.17, 7.01)

1.41 (-2.15, 5.50)

0.522

PUFA 20:4

3.05 (0.89, 6.68)*

0 (ref)

1.45 (0.11, 3.41)*

3.51 (-0.40, 8.12)

5.56 (1.35, 12.08)*

0.027

PUFA 20:5

3.69 (1.31, 5.85)*

0 (ref)

1.22 (0.01, 2.28)*

4.11 (1.20, 7.31)*

8.10 (2.02, 15.86)*

< 0.001

PUFA 22:5

5.15 (1.16, 11.33)*

0 (ref)

3.51 (1.06, 7.25)*

6.00 (1.41, 13.20)*

11.21 (3.36, 20.98)*

0.002

PUFA 22:6

6.40 (1.51, 10.87)*

0 (ref)

4.02 (0.50, 8.15)*

4.80 (1.12, 9.57)*

12.11 (1.97, 22.62)*

< 0.001

  1. Models were adjusted for sex, age, race, education, diabetes, and energy. Continuous, Ln-transformed concentration of fatty acids; Q, quartile; 95% CI, 95% confidence interval; PTA, Pure-tone average; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. * indicates p < 0.05, indicating statistical significance.